Found on pharmacist.com
Group by:
Title Date Type
FDA issues guide to support responsible opioid prescribing for pain management in animals
FDA News Release (08/15/18) Gottlieb, Scott
FDA Commissioner Scott Gottlieb reports the agency is releasing "important information for veterinarians to ensure they have additional context regarding the potential for people to misuse the products that they are prescribing to their animal patients." Among the recommendations for veterinarians…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
Smoking cessation, weight change, type 2 diabetes, and mortality
New England Journal of Medicine (08/16/18) Vol. 379, No. 7, P. 623 Hu, Yang; Zong, Geng; Liu, Gang; et al.
New research shows there is a temporary increase in the risk of type 2 diabetes after smoking cessation, mostly among individuals who gained weight. However, the researchers note, that "both cardiovascular and all-cause mortality decreased on smoking cessation, and the reduction was largely…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
Measles outbreak reported in 21 states, according to CDC
WXYZ News (Detroit) (08/15/18) Stringini, Mary
From January 1 to July 14, 2018, more than 100 people from 21 states and Washington, DC, have contracted measles, according to CDC. The highly contagious virus is easily spread by air droplets when infected individuals breathe, cough, or sneeze. CDC noted that most people who contracted the disease…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
Prenatal Tdap vaccination and autism spectrum disorder
Pediatrics (08/13/18) Becerra-Culqui, Tracy A.; Getahun, Darios; Chiu, Vicki; et al.
While previous research has ruled out any association between preterm delivery or low birth weight in babies whose mothers underwent prenatal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination, investigators wondered about the risk of autism spectrum disorders (ASD). They conducted a…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
Real-world evidence and real-world data for evaluating drug safety and effectiveness
Journal of the American Medical Association (08/13/18) Corrigan-Curay, Jacqueline; Sacks, Leonard; Woodcock, Janet
The dominance of randomized clinical trials beginning in the late 1940s shifted medical research away from practice-based observations, known as "real-world evidence." While the benefits have included greater rigor and reduced risk for bias, writes Janet Woodcock, director of FDA's Center for Drug…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
New estimates show overdose deaths surpassed 72,000, a new high, in 2017
New York Times (08/15/18) Sanger-Katz, Margot
There were approximately 72,000 overdose deaths in the United States last year, about a 10% increase from 2016, according to preliminary CDC estimates. The figures reflect two factors: a growing number of Americans are using opioids, and that these drugs are becoming deadlier as strong synthetic…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
Program developed for ND pharmacists to aid in prevention of opioid abuse
Bismarck Tribune (ND) (08/16/18) Emerson, Blair
The North Dakota State University School of Pharmacy on Wednesday unveiled a new training program to educate pharmacists on how to spot patients at risk of abusing opioids, as well as increase the number of naloxone prescriptions. "None of us are out of the reach of this (opioid) epidemic," said…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
EMS naloxone use jumps 75% in 4 years, CDC says
Becker's Hospital Review (08/13/18) Cook, Harrison
A new CDC report shows that emergency medical services' (EMS) use of naloxone has increased sharply in recent years. Using data from the National Emergency Medical Services Information system, the researchers found the rate of EMS naloxone administration rose to 1,004.4 administrations per 100,000…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
The next phase of human gene-therapy oversight
New England Journal of Medicine (08/15/18) Collins, Francis S.; Gottlieb, Scott
NIH and FDA are proposing new initiatives to promote further advances in the rapidly changing field of human gene therapy. In a Perspective piece in the New England Journal of Medicine, NIH Director Francis S. Collins, MD, and FDA Commissioner Scott Gottlieb, MD, state that it is time to reassess…
Aug 15, 2018 Publication Pharmacy Today Daily Edition
Oregon's Medicaid program weighs cutting off chronic pain patients from opioids
STAT News (08/15/18) Facher, Lev
Oregon officials are considering a first-in-the-nation plan to end coverage of opioids for many chronic pain patients enrolled in the state Medicaid program. Starting in 2020, these patients would see their opioid doses eliminated over the course of 12 months. Officials could potentially approve…
Aug 15, 2018 Publication Pharmacy Today Daily Edition